Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475.
Richard Wayne Joseph
No relevant relationships to disclose
Jeroen Elassaiss-Schaap
Employment or Leadership Position - Merck Sharp & Dohme
Jedd D. Wolchok
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck
Anthony M. Joshua
Consultant or Advisory Role - Merck (U)
Antoni Ribas
Consultant or Advisory Role - Amgen; Genentech; GlaxoSmithKline; Merck
Stock Ownership - Kite Pharma
F. Stephen Hodi
Consultant or Advisory Role - Merck (U)
Research Funding - Merck
Omid Hamid
Consultant or Advisory Role - Merck
Research Funding - Merck
Caroline Robert
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Adil Daud
Consultant or Advisory Role - Merck; OncoSec
Research Funding - Merck
Wen-Jen Hwu
Consultant or Advisory Role - Merck; Novartis
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck
Richard Kefford
Consultant or Advisory Role - Merck
Honoraria - Merck
Other Remuneration - Merck
Peter Hersey
No relevant relationships to disclose
Jeffrey S. Weber
Consultant or Advisory Role - Merck
Honoraria - Merck
Research Funding - Merck
Amita Patnaik
Research Funding - Merck
Dinesh Prasad De Alwis
Employment or Leadership Position - Merck
Stock Ownership - Merck
Andrea Marie Perrone
Employment or Leadership Position - Merck
Stock Ownership - Merck (I); Merck
Soonmo Peter Kang
Employment or Leadership Position - Merck
Scot Ebbinghaus
Employment or Leadership Position - Merck
Stock Ownership - Merck
Keaven M. Anderson
Employment or Leadership Position - Merck
Stock Ownership - Merck
Tara C. Gangadhar
No relevant relationships to disclose